This study evaluated in vitro interactions of antituberculosis drugs and triazoles against Histoplasma capsulatum. Nine drug combinations, each including an antituberculosis drug (isoniazid, pyrazinamide, or ethambutol) plus a triazole (itraconazole, fluconazole, or voriconazole), were tested against both growth forms of H. capsulatum. Stronger synergistic interactions were seen in isoniazid or pyrazinamide plus triazoles for the mold form and ethambutol plus voriconazole for the yeast-like form. Further studies should evaluate these combinations in vivo.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165363 | PMC |
| http://dx.doi.org/10.1128/AAC.01471-10 | DOI Listing |
Publication Analysis
Top Keywords
antituberculosis drugs
8
histoplasma capsulatum
8
isoniazid pyrazinamide
8
synergistic antituberculosis
4
drugs azoles
4
azoles vitro
4
vitro histoplasma
4
capsulatum
4
capsulatum var
4
var capsulatum
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!